XML 47 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders Equity (Tables)
9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Summary of Recognized Stock-based Compensation Expense for Employees and Non-employees

The Company recognized stock-based compensation for its employees and non-employees in the accompanying condensed consolidated statements of operations as follows:

 

 

 

Three Months

Ended September 30

 

 

Nine Months

Ended September 30

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cost of sales

 

$

6

 

 

$

 

 

$

18

 

 

$

 

Selling and marketing

 

 

234

 

 

 

121

 

 

 

647

 

 

 

954

 

General and administrative

 

 

285

 

 

 

190

 

 

 

869

 

 

 

694

 

Research and development

 

 

22

 

 

 

2

 

 

 

69

 

 

 

84

 

Total stock-based compensation

 

$

547

 

 

$

313

 

 

$

1,603

 

 

$

1,732

 

Assumptions used in Fair Value of Option Estimated at Date of Grant using Black-Scholes-Merton Option Pricing Formula

The fair value of each option is estimated at the date of grant using the Black-Scholes option pricing formula with the following assumptions:

 

 

 

Three Months

Ended September 30

 

 

Nine Months

Ended September 30

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Expected term (in years)

 

 

6.04

 

 

 

4.36

 

 

5.00-6.54

 

 

4.00-5.00

 

Risk-free interest rate

 

0.38 -0.40

%

 

 

2.43

%

 

0.38-1.50

%

 

1.4-2.53

%

Expected volatility

 

 

44.30

%

 

 

50.00

%

 

 

42.81

%

 

 

49.00

%

Expected dividend rate

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Summary of Stock Option Activity

The following table summarizes stock option activity under the Company’s stock option plans:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price per

Share,

$

 

 

Weighted-

Average

Remaining

Contractual

Term

 

 

Aggregate

Intrinsic

Value

 

Outstanding – January 1, 2020

 

 

3,278,439

 

 

$

5.29

 

 

 

5.08

 

 

$

4,885

 

Options granted

 

 

1,944,000

 

 

 

4.20

 

 

 

 

 

 

 

-

 

Options exercised

 

 

(48,588

)

 

 

3.59

 

 

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

(288,654

)

 

 

15.91

 

 

 

 

 

 

 

 

 

Outstanding – September 30, 2020

 

 

4,885,197

 

 

$

4.27

 

 

 

6.01

 

 

$

1,326

 

Exercisable – September 30, 2020

 

 

2,894,591

 

 

$

3.82

 

 

 

3.77

 

 

$

1,326

 

Expected to vest – after September 30, 2020

 

 

1,990,606

 

 

$

4.91

 

 

 

9.27

 

 

$

-

 

Summary of Information about Stock Options Outstanding and Exercisable

 

The following tables summarize information about stock options outstanding and exercisable at September 30, 2020:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise Price Range

 

Number

 

 

Weighted

average

remaining

contractual

term

(years)

 

 

Weighted

average

Exercise

Price

 

 

Options

exercisable

 

 

Weighted

average

remaining

contractual

term

(years)

 

 

Weighted

average

Exercise

Price

 

$0.15 - $3.64

 

 

3,323,945

 

 

 

5.62

 

 

$

2.77

 

 

 

1,988,636

 

 

 

2.98

 

 

$

2.24

 

$4.26 - $7.95

 

 

1,503,766

 

 

 

6.84

 

 

 

6.79

 

 

 

866,968

 

 

 

5.46

 

 

 

6.38

 

$12.45 - $26.10

 

 

35,011

 

 

 

7.97

 

 

 

18.45

 

 

 

17,511

 

 

 

7.80

 

 

 

18.96

 

$27.00 - $33.00

 

 

13,564

 

 

 

3.93

 

 

 

27.94

 

 

 

13,514

 

 

 

3.92

 

 

 

27.94

 

$36.00 - $94.65

 

 

8,911

 

 

 

6.76

 

 

 

46.29

 

 

 

7,962

 

 

 

6.75

 

 

 

45.16

 

 

 

 

4,885,197

 

 

 

6.01

 

 

$

4.27

 

 

 

2,894,591

 

 

 

3.77

 

 

$

3.82